HOME >> MEDICINE >> NEWS
Mount Sinai expands cutting-edge molecular testing

Today, Mount Sinai Hospital, announced that it has signed a three-year strategic alliance agreement with world-renowned diagnostic company Roche Diagnostics, to establish a Molecular Center of Excellence (MCOE). As a Roche designated MCOE, the Molecular Pathology Laboratory will offer physicians and patients the most advanced molecular diagnostics technologies such as Roche Diagnostics' patented Polymerase Chain Reaction (PCR), which is more sensitive and more specific than traditional diagnostic methods such as culture.

The Molecular Pathology Laboratory at Mount Sinai, through the leadership of Dr. David Zhang, has become nationally recognized for excellence in technology-based research and clinical molecular diagnostics. More than 6,000 medical laboratory tests are performed each year including 1) tests for infectious agents, such as Human Papiloma Virus and Epstein-Barr virus; 2) tests for genetic disorders, such as Factor V Leiden and Factor II (Prothrombin) gene mutation tests that provide fast and accurate tools to aid in the diagnosis and evaluation of patients with suspected thrombophilia; and 3) tumor oncology assays, such as tests for certain lymphocyte gene rearrangement which act as diagnostic markers for certain lymphomas and leukemias. These tests and other molecular diagnostics tests performed at Mount Sinai allow physicians to diagnose, treat and monitor diseases but most importantly, improve the lives of many patients seen at Mount Sinai.

"We are very excited to partner with Roche Diagnostics, a leader in the diagnostics industry," said David Zhang, MD, PhD, director of the Molecular Pathology Laboratory at Mount Sinai. "With the combination of Roche's cutting edge technologies and our expertise in clinical molecular diagnosis, we will be able to offer the most advanced diagnostic testing to Mount Sinai clinicians to assist with diagnosis, prescription and prognosis. The Molecular Pathology Laboratory has always strived for excel
'"/>

Contact: Mount Sinai Press Office
newsmedia@mssm.org
212-241-9200
The Mount Sinai Hospital / Mount Sinai School of Medicine
18-Jan-2006


Page: 1 2

Related medicine news :

1. New breakthrough treatment for spinal cancer patients at Mount Sinai
2. Mount Sinai and EXACT Sciences announce study results on study stool DNA testing for colon cancer
3. Wiley to assume publication of Mount Sinai Journal of Medicine
4. Mount Sinai researcher finds drinking water safe to drink
5. The Mount Sinai Medical Center recognized for excellence in bariatric surgery
6. Mount Sinai Global Health Center receives $1M grant
7. Mount Sinai School of Medicine receives prestigious AAMC Grant for Chronic Illness Care education
8. Mount Sinai and YAI/NIPD Network join forces to further quality of care for people with autism
9. Mount Sinai launches combination therapy trial to treat Relapsing-Remitting Multiple Sclerosis
10. CNIC commits 5 million Euros to the Mount Sinai School of Medicine
11. Mountain bikers are cautioned to ride with care - major injuries do happen

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Mount Sinai expands cutting edge molecular testing

(Date:1/22/2015)... For over 20 years, Dr. David Cruz of ... area has treated just about every type of injury that ... And for those same twenty-plus years, the team at Doctors ... with the best possible doctor. With the combined breadth ...
(Date:1/22/2015)... 2015 Joan Lunden, award-winning American journalist, ... the upcoming 32nd Annual Miami Breast Cancer Conference ... Resource®, LLC (PER®) , shares that “a fast-growing, virulent” ... if she had not followed up her clean mammogram ...
(Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 IsoComforter, Inc. has ... machine with patented IsoTube design to treat specific body parts ... the most progressive and easy to use patented cold therapy ... and sports related orthopedic and muscle injuries. IsoComforter has ...
(Date:1/22/2015)... Payday lending practices in four southern ... financial distress to the states that permit them, according ... Center on Race and Wealth. , While they generate ... loans at the same time substantially depress economic activity, ...
Breaking Medicine News(10 mins):Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2
(Date:1/23/2015)... N.Y. , Jan. 23, 2015  Lixte Biotechnology Holdings, Inc. ... its Phase I trial of Lixte,s lead compound, LB‑100, is ... John S. Kovach , M.D., the founder ... planned to be completed at a single site. Accrual of ...
(Date:1/23/2015)... Jan. 23, 2015  Mallinckrodt plc (NYSE: MNK ... approved a share repurchase program. The open-ended authorization permits ... Mallinckrodt plc ordinary shares. "Funding additional ... priorities as we continue to pursue a range of ...
(Date:1/22/2015)... privately held medical device company, announced today that it ... Corporation (Tokyo Stock Exchange TYO: 8001) to sell its ... in Japan . ViewRay,s technology, the ... MRI-guided radiation therapy system that images and treats cancer ...
Breaking Medicine Technology:Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 2Lixte Biotechnology Holdings Announces Expansion Of Clinical Sites For Its Phase I Trial Of Its Lead Anti-Cancer Compound, LB-100 3Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2
Cached News: